Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2022 · 10-Q
Revenue$269.28M$269.28M+20.1% vs Q2 2021 Net Income$80.17M$80.17M+73.3% vs Q2 2021 EPS Diluted$0.49$0.49−57.4% vs Q2 2021 Gross Profit$183,691,000+21.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$100,993,000+13.1% Free Cash Flowderived$90,825,000+16.7% Margins · derivedGross margin68.2%+0.9 pt vs Q2 2021
Operating margin23.2%+0.4 pt vs Q2 2021
Net margin29.8%+9.1 pt vs Q2 2021
ended Dec 31, 2021 · filed Feb 7, 2022 · 38 d after period end